Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial

BACKGROUND: Understanding which group of patients with type 2 diabetes will have the most glucose lowering response to certain medications (which target different aspects of glucose metabolism) is the first step in precision medicine. AIMS: We hypothesized that people with type 2 diabetes who genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandon, Rebecca, Jiang, Yannan, Yeu, Rui Qian, Tweedie-Cullen, Ry, Smallman, Kate, Doherty, Glenn, Macaskill-Smith, Kerry A., Doran, Rebekah J., Clark, Penny, Moffitt, Allan, Merry, Troy, Nehren, Norma, King, Frances, Hindmarsh, Jennie Harré, Leask, Megan Patricia, Merriman, Tony R., Orr-Walker, Brandon, Shepherd, Peter R., Paul, Ryan, Murphy, Rinki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869378/
https://www.ncbi.nlm.nih.gov/pubmed/36699039
http://dx.doi.org/10.3389/fendo.2022.1091421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869378/
https://www.ncbi.nlm.nih.gov/pubmed/36699039
http://dx.doi.org/10.3389/fendo.2022.1091421

Ejemplares similares